Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction
The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by GAAD Medical Research Institute Inc..
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
GAAD Medical Research Institute Inc.
Information provided by:
GAAD Medical Research Institute Inc.
ClinicalTrials.gov Identifier:
NCT00573209
First received: December 12, 2007
Last updated: August 14, 2009
Last verified: August 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A preliminary study to determine the possibility of using far infrared (FIR) radiation to treat impotency.
| Condition | Intervention | Phase |
|---|---|---|
|
Erectile Dysfunction |
Radiation: Far Infrared Radiation |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction. |
Resource links provided by NLM:
Further study details as provided by GAAD Medical Research Institute Inc.:
Primary Outcome Measures:
- The primary end point is to determine the therapeutic effects of far infrared radiation on erectile dysfunction. [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- The effect of far infrared radiation on other male conditions like prostate cancer [ Time Frame: 1 year ] [ Designated as safety issue: No ]
| Enrollment: | 3 |
| Study Start Date: | August 2007 |
| Estimated Study Completion Date: | May 2009 |
| Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| 1 |
Radiation: Far Infrared Radiation
Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session.
|
Detailed Description:
Erectile dysfunction is characterized by the regular or repeated inability to obtain or maintain an erection. Erection depends on a complex interaction of psychological, neural, vascular and endocrine factors.
We are proposing a non-drug and a non-invasive radiation treatment for the enhancement of erection.
Eligibility| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Persons with erection challenges
Exclusion Criteria:
- None
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00573209
Locations
| Canada, Ontario | |
| The Centre for Incurable Diseases | |
| Mississauga, Ontario, Canada, L5R 3G9 | |
Sponsors and Collaborators
GAAD Medical Research Institute Inc.
Investigators
| Study Director: | Ken Nedd, M.D. | GAAD Medical Research Institute Inc. |
| Study Chair: | Kwasi Donyina, Ph.D. | GAAD Medical Research Institute Inc. |
More Information
No publications provided
| Responsible Party: | Dr. Kwasi Donyina/Founder & President, GAAD Medical Research Institute inc. |
| ClinicalTrials.gov Identifier: | NCT00573209 History of Changes |
| Other Study ID Numbers: | GAAD-EDS-CTP1 |
| Study First Received: | December 12, 2007 |
| Last Updated: | August 14, 2009 |
| Health Authority: | Canada: Health Canada |
Keywords provided by GAAD Medical Research Institute Inc.:
|
Impotence Male Impotence Male Sexual Impotence |
Additional relevant MeSH terms:
|
Erectile Dysfunction Sexual Dysfunction, Physiological Genital Diseases, Male |
Sexual Dysfunctions, Psychological Sexual and Gender Disorders Mental Disorders |
ClinicalTrials.gov processed this record on June 18, 2013